Standard BioTools Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 106.34 million compared to USD 97.95 million a year ago. Net loss was USD 74.66 million compared to USD 190.1 million a year ago.

Basic loss per share from continuing operations was USD 0.94 compared to USD 2.43 a year ago.